-
FamilyWize’s New Medicine Cabinet Feature Allows Users to Personalize Their Prescription Drug Price Search on Their Website
Post on 1/23/17
-
Teva Has Got Potential - And The Complexity To Go With It
Post on 1/23/17
-
Johnson & Johnson Earnings Preview: Don't Expect Big Surprises
Post on 1/23/17
-
Better Buy: GlaxoSmithKline PLC vs. Johnson & Johnson
Post on 1/23/17
-
Can Johnson & Johnson Sustain Its Growth in 2017?
Post on 1/23/17
-
How Will Pfizer Inc. Fare Under President Trump?
Post on 1/23/17
-
Better Buy: Merck & Co. Inc. vs. Pfizer
Post on 1/23/17
-
Top Biotech Stocks to Buy in 2017
Post on 1/23/17
-
Should You Be Afraid of Huge Medicare Changes Under President Trump?
Post on 1/23/17
-
Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and License Agreement with Merck
Post on 1/22/17
-
Amarin Announces Debt Restructuring
Post on 1/20/17
-
Egalet: A Promising Company Currently On Sale
Post on 1/20/17
-
Matinas BioPharma Completes Warrant Tender Offer – Raises $13.5 Million from Exercise of Warrants
Post on 1/19/17
-
Decisio Health Selects Resound Marketing as Public Relations Agency of Record
Post on 1/19/17
-
5 Most Important Drugs to Johnson & Johnson in 2017
Post on 1/19/17
-
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post on 1/19/17
-
Egalet Closes Second Tranche of $80 Million Secured Debt Financing
Post on 1/18/17
-
Better Buy: Amgen Inc. vs. Celgene Corporation
Post on 1/18/17
-
Should Pfizer, Inc. Be on Your Stock Watchlist?
Post on 1/18/17
-
Health Partners Plans Names Matthew Post VP of Medicare Sales
Post on 1/17/17
-
Nursing Shortage Inspires Action at BAYADA Home Health Care
Post on 1/17/17
-
Is Donald Trump Big Pharma's Worst Nightmare?
Post on 1/17/17
-
Trumpcare, Not Obamacare, Could Be a Job Killer
Post on 1/17/17
-
Does Johnson & Johnson Pass the Buffett Test?
Post on 1/17/17
-
Akers Biosciences Closes Public Offering
Post on 1/16/17
Philadelphia
